Physician

Nephrology

Dr. Andrew J. Lewin, MD

Andrew Lewin is an expert in the field of Nephrology. He went to medical school at NYU School of Medicine. Andrew Lewin is also a published physician. He has 38 publication published. The most recent publication is: An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.

Publications

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
Empagliflozin added to metformin and sulfonylurea therapy in patients with sub-optimally controlled type 2 diabetes mellitus.
Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment.
Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age.
Nebivolol Monotherapy for Patients With Systolic Stage II Hypertension: Results of a Randomized, Placebo-Controlled Trial.
Efficacy and Tolerability of Linagliptin Added to a Sulfonylurea Regimen in Patients With Inadequately Controlled Type 2 Diabetes Mellitus: An 18-Week, Multicenter, Ra...
Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status...
Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide.
The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System.
Basal insulin or premix analogue therapy in type 2 diabetes patients.
A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertension.
Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension.
Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patien...
Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, ...
Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfony...
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension.
Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.
There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients.
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hyp...
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes.
Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes.
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-...
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicent...
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*.
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treat...
Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open piogl...
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2...
Acetylsalicylic acid reduces niacin extended-release-induced flushing in patients with dyslipidemia.

Schools

New York University School Of Medicine
Bellevue Hospital Center
UCLA Med Center
Wadsworth Va Hospital
Cedars Sinai Med Center

Doctors Specialties

Nephrology

Accepted Insurances

Education

Cedars-Sinai Medical Center
VA Greater Los Angeles Healthcare System
UCLA Medical Center
NYU School of Medicine

Hospital

Cedars-Sinai Medical Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Keith L. Agre, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph A. Abdelmalek, MD This Doctor is OpenDoctor Recommended.
	Dr. Anjana V. Kamdar, MD This Doctor is OpenDoctor Recommended.
	Dr. Yee Lu, MD This Doctor is OpenDoctor Recommended.
	Dr. Hosameldin Madkour, MD This Doctor is OpenDoctor Recommended.
	Dr. Ira B. Kurtz, MD This Doctor is OpenDoctor Recommended.
	Dr. Franklin G. Strauss, MD This Doctor is OpenDoctor Recommended.
	Dr. Elsa M. Aguiniga, MD This Doctor is OpenDoctor Recommended.
	Dr. Suphamai Bunnapradist, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Orlando Camacho, MD This Doctor is OpenDoctor Recommended.
	Dr. Jingbo Huang, MD
	Dr. Margarita Symonian, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarinya Boongird, MD